Pitch Patch Augmentation for Shoulder Injuries

Phase-Based Progress Estimates
Stanford University, Redwood City, CA
Shoulder Injuries
Pitch Patch Augmentation - Procedure
All Sexes
What conditions do you have?

Study Summary

The primary purpose of this research is to compare the images obtained by ultrasound between a standard repair of the subscapularis tissue and after repair with a patch. The secondary purpose is to determine if there are any clinical differences.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 3 Secondary · Reporting Duration: 3 months, 1 years after surgery

Year 2
American Shoulder & Elbow Surgeons Score (ASES) score
Difference in signs of loosening or wear patterns in shoulder X-Ray
Shoulder examination for the difference in Passive Range of Motion
Year 1
Difference in continuity of subscapularis tissue on ultrasound
Difference in thickness of the subscapularis tissue on ultrasound
Year 2
Shoulder examination for the difference in Active Range of Motion
Evaluate arthritis on shoulder x-ray

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Standard Repair with Sutures
1 of 2
Pitch Patch Augmentation
1 of 2
Active Control
Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Pitch Patch Augmentation · No Placebo Group · N/A

Pitch Patch Augmentation
Experimental Group · 1 Intervention: Pitch Patch Augmentation · Intervention Types: Procedure
Standard Repair with Sutures
ActiveComparator Group · 1 Intervention: Standard Repair with Sutures · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months, 1 years after surgery

Trial Background

Prof. Michael T. Freehill, Associate Professor of Orthopaedic Surgery
Principal Investigator
Stanford University
Closest Location: Stanford University · Redwood City, CA
Photo of Stanford University  1Photo of Stanford University  2Photo of Stanford University  3
1992First Recorded Clinical Trial
2 TrialsResearching Shoulder Injuries
768 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.